Quit Smoking, Vaping, Alcohol

How to Quit Vaping: What the Evidence Actually Says

· the team behind the app

Most articles about quitting vaping are written as though the answer is settled. It isn’t — and pretending otherwise does you no favours.

Quitting smoking has been studied for decades across hundreds of trials, so we know with real confidence what works. Quitting vaping is a much newer question: the trials are few, they’re small, and the researchers who pooled them rated most findings as low certainty. That’s not a reason to give up. It’s a reason to know which parts of the advice below are solid, which are educated guesses, and which are honestly unknown — because a reader who knows the difference makes better decisions than one handed false confidence.

The evidence base, honestly

The best current summary is the Cochrane review Interventions for quitting vaping (Butler et al., 2025). Cochrane reviews are the closest thing medicine has to a neutral referee: they pool every trial that meets a quality bar, then grade how much you should trust the result. Their grade for almost everything here was low.

What “low certainty” actually means

It does not mean “this doesn’t work.” It means: if better trials are run, the answer could change substantially, and possibly reverse. Certainty gets downgraded for small participant numbers, wide statistical ranges, and study design flaws. In the vaping literature the main culprit is simply size — a couple of hundred people is not enough to pin down an effect.

The practical translation: low-certainty findings are worth acting on when the intervention is cheap, safe, and easy to stop. They’re worth discussing with a professional when it’s a prescription medicine. They’re not worth building your whole plan around.

The strongest signal so far: varenicline

Varenicline is a prescription medicine developed for smoking cessation. It’s the one treatment in the review with a clear positive result for vaping.

Cochrane found that varenicline increased vaping cessation at six months compared with placebo — a risk ratio of 2.71, meaning people on varenicline were roughly two and a half to three times as likely to have quit.

Now the honest part. That comes from 2 studies and 315 participants in total, and the 95% confidence interval runs from 1.33 to 5.49. In plain English: the effect is probably real and positive, but it could be a modest bump or a large one — the data can’t tell us which. Cochrane rated it low certainty because of that imprecision.

So: promising, worth asking about, not a guarantee. Varenicline is prescription-only in most countries and availability has varied in recent years, so your pharmacist will know the local situation. And this article deliberately contains no dosing or starting instructions — that’s a conversation for someone who knows your history, not a web page.

Text-message support: cheap, low-risk, real signal

The same review found that text-message support programmes may help youths and young adults stop vaping, compared with no support or minimal support. Also low certainty — but this one is much easier to act on, because the downside is a few texts a day.

This matters more than usual here, because vaping skews young — a lot of people trying to quit are in exactly the group these programmes were built for and tested in.

Two that are free:

Availability differs by country; many national health services run an equivalent. The logic is straightforward risk-reward: low certainty of benefit, essentially zero cost and zero risk. That’s a bet worth taking.

What’s genuinely unknown

This is the section most quit-vaping guides skip. Cochrane looked at several plausible approaches and concluded the evidence is inconclusive — too much risk of bias, too much imprecision — for:

Unknown isn’t the same as useless — plenty of things that work were unproven until someone ran the trial. But if you taper your nicotine strength and it doesn’t get you to zero, that’s not a personal failure; you were using a method nobody has yet shown works. Our quit vaping timeline covers how to taper with a real end date, the version least likely to become indefinite maintenance.

What you can borrow from smoking research — carefully

Nicotine is nicotine. The molecule that keeps you reaching for a pod is the same one that kept your grandfather reaching for a pack, acting on the same receptors. That’s the argument for extrapolating from the much stronger smoking evidence — and it’s a reasonable argument, but it is an argument, not proof. Delivery speed, dose, and the population using each product all differ.

With that caveat attached, here’s what the smoking literature establishes (Livingstone-Banks et al., 2024, in Addiction): all the main pharmacological treatments work, varenicline and cytisine are among the most effective, and nicotine replacement therapy works best when a patch is combined with a fast-acting form rather than used alone.

Cytisine is comparable to other recommended products in effect, safety and cost, and clearly beats placebo or usual care for smoking; it’s long-established and inexpensive across Central and Eastern Europe, sold under names such as Tabex. Whether any of this carries across to vaping is the open question — but it’s the most defensible thing to raise with a doctor once the vaping-specific evidence runs out.

One clarification, because the headlines confuse everyone

You will run into research saying nicotine e-cigarettes are among the most effective ways to quit. That research is about quitting cigarettes — a completely different question, with no bearing on how to stop vaping. Don’t let a headline about smokers talk you out of your own quit.

Why vaping is uniquely hard to quit

No trial needed for this part — it falls out of the design of the product.

A cigarette has a built-in ending. It burns down, it smells, it makes you go outside, it produces ash someone will comment on. Every one of those is friction, and friction creates natural gaps in the habit.

A vape has none of it. No smell, no ash, no stepping out, no social cost, no point at which the object tells you you’re finished. So it expands to fill every idle moment — the lift, the queue, the two minutes between meetings, the bed. Instead of fifteen or twenty discrete events a day, you may be running hundreds of micro-repetitions. That’s why it can feel harder to quit than smoking despite being physically easier: you’re unwinding far more reps of a far more automatic loop.

Map your triggers, break the hand-to-mouth loop

Because the habit is built from repetitions rather than rituals, the fix is repetition-level too.

Map it before you quit. For three days, note every time you reach for the vape and what was happening one minute earlier. Most people find five or six cues doing eighty percent of the work — the first coffee, opening the laptop, the drive home, the third drink, the moment a task gets boring.

Plan each cue individually. Not “I’ll resist” — a specific substitute action for that specific moment. Cold water, a walk to the end of the corridor, gum, hands on the keyboard instead of the pocket.

Give the hand something to do. The hand-to-mouth motion outlives the nicotine by weeks. That reflex isn’t weakness; it’s motor memory with tens of thousands of reps behind it, and it fades faster when replaced than when simply denied.

Expect cravings to be short. They crest and pass, usually within minutes. You don’t have to win an argument with a craving — you have to outlast it.

Why counting days helps, even without a trial to prove it

In keeping with the spirit of this article: there is no randomised trial showing a day counter helps you quit vaping. What there is, is a mechanism that makes sense and that a great many people describe.

Quitting vaping is mostly invisible. Nothing about your appearance changes, nobody congratulates you, and the reward — not having a habit — is an absence rather than a presence. That’s a poor feedback structure for a brain that learns from visible signals.

A day count converts the invisible into something concrete. Day 9 becomes an object you own and won’t casually throw away. The money not spent on pods becomes a real number. And the 30-day mark stops being a vague someday and becomes a date you can watch approaching — the sobriety calculator will tell you exactly when it lands.

Count your days, not your slip-ups. The Quit Smoking, Vaping, Alcohol app is a free, private day counter for quitting vaping, smoking, drinking, or any habit — milestones, money saved, and health progress, one day at a time. Download on the App Store · Get it on Google Play

Frequently asked questions

What is the single most effective way to quit vaping?

Nobody can honestly say yet. Varenicline has the strongest trial result so far, but from only two studies and 315 people, rated low certainty. The realistic answer is a combination: a quit date, a trigger plan, free text support, and a conversation with a doctor about medication.

Is it better to quit vaping cold turkey or taper down?

The evidence doesn’t settle it — Cochrane found vaping-reduction approaches inconclusive. What’s clear is that tapering without a fixed end date tends to become permanent maintenance. If you taper, write down the date you reach zero and treat that day as the real quit.

Should I ask my doctor about medication?

If cravings keep ending your attempts, yes. Bring what you know: varenicline is the one with a positive vaping trial result, and smoking-cessation evidence is stronger for varenicline, cytisine, and combination NRT. Availability differs by country and several are prescription-only. Let the clinician decide what fits you.

Sources and further reading

This article is for information only and isn’t medical advice. Availability of the medicines mentioned varies by country and several are prescription-only — talk to a doctor or pharmacist about what’s right for you.